<i>Spirulina maxima</i> Decreases Endothelial Damage and Oxidative Stress Indicators in Patients with Systemic Arterial Hypertension: Results from Exploratory Controlled Clinical Trial

(1) Background: <i>Spirulina</i> (<i>Arthrospira</i>) <i>maxima</i> has shown beneficial effects such as being anti-dyslipidemic, antiviral, antioxidant and antihypertensive. However, there are few and limited clinical studies. (2) Methods: a prospective, randomiz...

Full description

Bibliographic Details
Main Authors: Jesús Martínez-Sámano, Adriana Torres-Montes de Oca, Oscar Ivan Luqueño-Bocardo, Patricia V. Torres-Durán, Marco A. Juárez-Oropeza
Format: Article
Language:English
Published: MDPI AG 2018-12-01
Series:Marine Drugs
Subjects:
Online Access:https://www.mdpi.com/1660-3397/16/12/496
id doaj-817fa08338cb404d8de73dd9831aea87
record_format Article
spelling doaj-817fa08338cb404d8de73dd9831aea872020-11-24T20:42:46ZengMDPI AGMarine Drugs1660-33972018-12-01161249610.3390/md16120496md16120496<i>Spirulina maxima</i> Decreases Endothelial Damage and Oxidative Stress Indicators in Patients with Systemic Arterial Hypertension: Results from Exploratory Controlled Clinical TrialJesús Martínez-Sámano0Adriana Torres-Montes de Oca1Oscar Ivan Luqueño-Bocardo2Patricia V. Torres-Durán3Marco A. Juárez-Oropeza4Departamento de Bioquímica, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México 04510, MexicoDepartamento de Bioquímica, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México 04510, MexicoDepartamento de Bioquímica, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México 04510, MexicoDepartamento de Bioquímica, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México 04510, MexicoDepartamento de Bioquímica, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México 04510, Mexico(1) Background: <i>Spirulina</i> (<i>Arthrospira</i>) <i>maxima</i> has shown beneficial effects such as being anti-dyslipidemic, antiviral, antioxidant and antihypertensive. However, there are few and limited clinical studies. (2) Methods: a prospective, randomized, parallel pilot study of 4.5 g administration of <i>Spirulina</i> <i>maxima</i> or placebo for 12 weeks in 16 patients with systemic arterial hypertension (SAH) undergoing treatment with angiotensin-converting enzyme (ACE) inhibitors was performed to assess the effects on endothelial damage and oxidative stress indicators. The blood levels of sICAM-1, sVCAM-1, endothelin-1, and sE-selectin were quantified; the activities of catalase, superoxide dismutase, glutathione peroxidase, glutathione reductase and concentrations of reduced glutathione, oxidized glutathione, and thiobarbituric acid reactive substances, were also quantified before and after the treatment period. (3) Results: There were statistically significant (<i>p</i> &lt; 0.05) decreases in systolic blood pressure, sVCAM-1, sE-selectin and endothelin-1 levels, and increases in glutathione peroxidase activity and oxidized glutathione levels. (4) Conclusion: The effects found in the present study agree with antihypertensive and antioxidant effects previously reported for <i>Spirulina maxima</i>. However, this is the first report about the effects on indicators of endothelial damage. More research in this field is necessary to gain an insight into the effects of <i>Spirulina</i> on these indicators.https://www.mdpi.com/1660-3397/16/12/496<i>Arthrospira maxima</i>antioxidantcardiovascularnutraceuticalsystolic blood pressure
collection DOAJ
language English
format Article
sources DOAJ
author Jesús Martínez-Sámano
Adriana Torres-Montes de Oca
Oscar Ivan Luqueño-Bocardo
Patricia V. Torres-Durán
Marco A. Juárez-Oropeza
spellingShingle Jesús Martínez-Sámano
Adriana Torres-Montes de Oca
Oscar Ivan Luqueño-Bocardo
Patricia V. Torres-Durán
Marco A. Juárez-Oropeza
<i>Spirulina maxima</i> Decreases Endothelial Damage and Oxidative Stress Indicators in Patients with Systemic Arterial Hypertension: Results from Exploratory Controlled Clinical Trial
Marine Drugs
<i>Arthrospira maxima</i>
antioxidant
cardiovascular
nutraceutical
systolic blood pressure
author_facet Jesús Martínez-Sámano
Adriana Torres-Montes de Oca
Oscar Ivan Luqueño-Bocardo
Patricia V. Torres-Durán
Marco A. Juárez-Oropeza
author_sort Jesús Martínez-Sámano
title <i>Spirulina maxima</i> Decreases Endothelial Damage and Oxidative Stress Indicators in Patients with Systemic Arterial Hypertension: Results from Exploratory Controlled Clinical Trial
title_short <i>Spirulina maxima</i> Decreases Endothelial Damage and Oxidative Stress Indicators in Patients with Systemic Arterial Hypertension: Results from Exploratory Controlled Clinical Trial
title_full <i>Spirulina maxima</i> Decreases Endothelial Damage and Oxidative Stress Indicators in Patients with Systemic Arterial Hypertension: Results from Exploratory Controlled Clinical Trial
title_fullStr <i>Spirulina maxima</i> Decreases Endothelial Damage and Oxidative Stress Indicators in Patients with Systemic Arterial Hypertension: Results from Exploratory Controlled Clinical Trial
title_full_unstemmed <i>Spirulina maxima</i> Decreases Endothelial Damage and Oxidative Stress Indicators in Patients with Systemic Arterial Hypertension: Results from Exploratory Controlled Clinical Trial
title_sort <i>spirulina maxima</i> decreases endothelial damage and oxidative stress indicators in patients with systemic arterial hypertension: results from exploratory controlled clinical trial
publisher MDPI AG
series Marine Drugs
issn 1660-3397
publishDate 2018-12-01
description (1) Background: <i>Spirulina</i> (<i>Arthrospira</i>) <i>maxima</i> has shown beneficial effects such as being anti-dyslipidemic, antiviral, antioxidant and antihypertensive. However, there are few and limited clinical studies. (2) Methods: a prospective, randomized, parallel pilot study of 4.5 g administration of <i>Spirulina</i> <i>maxima</i> or placebo for 12 weeks in 16 patients with systemic arterial hypertension (SAH) undergoing treatment with angiotensin-converting enzyme (ACE) inhibitors was performed to assess the effects on endothelial damage and oxidative stress indicators. The blood levels of sICAM-1, sVCAM-1, endothelin-1, and sE-selectin were quantified; the activities of catalase, superoxide dismutase, glutathione peroxidase, glutathione reductase and concentrations of reduced glutathione, oxidized glutathione, and thiobarbituric acid reactive substances, were also quantified before and after the treatment period. (3) Results: There were statistically significant (<i>p</i> &lt; 0.05) decreases in systolic blood pressure, sVCAM-1, sE-selectin and endothelin-1 levels, and increases in glutathione peroxidase activity and oxidized glutathione levels. (4) Conclusion: The effects found in the present study agree with antihypertensive and antioxidant effects previously reported for <i>Spirulina maxima</i>. However, this is the first report about the effects on indicators of endothelial damage. More research in this field is necessary to gain an insight into the effects of <i>Spirulina</i> on these indicators.
topic <i>Arthrospira maxima</i>
antioxidant
cardiovascular
nutraceutical
systolic blood pressure
url https://www.mdpi.com/1660-3397/16/12/496
work_keys_str_mv AT jesusmartinezsamano ispirulinamaximaidecreasesendothelialdamageandoxidativestressindicatorsinpatientswithsystemicarterialhypertensionresultsfromexploratorycontrolledclinicaltrial
AT adrianatorresmontesdeoca ispirulinamaximaidecreasesendothelialdamageandoxidativestressindicatorsinpatientswithsystemicarterialhypertensionresultsfromexploratorycontrolledclinicaltrial
AT oscarivanluquenobocardo ispirulinamaximaidecreasesendothelialdamageandoxidativestressindicatorsinpatientswithsystemicarterialhypertensionresultsfromexploratorycontrolledclinicaltrial
AT patriciavtorresduran ispirulinamaximaidecreasesendothelialdamageandoxidativestressindicatorsinpatientswithsystemicarterialhypertensionresultsfromexploratorycontrolledclinicaltrial
AT marcoajuarezoropeza ispirulinamaximaidecreasesendothelialdamageandoxidativestressindicatorsinpatientswithsystemicarterialhypertensionresultsfromexploratorycontrolledclinicaltrial
_version_ 1716821815217618944